The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
Vigabatrin for Oral Solution USP, 500 mg had annual sales of US $233.7 mn in US
Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
Receives Subject Expert Committee recommendation to bring new therapies of Pompe, ASMD to India
New workflow integrates the xCELLigence RTCA HT with the BioTek BioSpa 8 Automated Incubator
IAGES to focus on upskilling and adoption of advanced Minimal Access Surgery technologies in 2023
Subscribe To Our Newsletter & Stay Updated
